A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
dc.contributor.author | Wai, Chun-Tao | en_US |
dc.contributor.author | Greenson, Joel K. | en_US |
dc.contributor.author | Fontana, Robert John | en_US |
dc.contributor.author | Kalbfleisch, John D. | en_US |
dc.contributor.author | Marrero, Jorge A. | en_US |
dc.contributor.author | Conjeevaram, Hari S. | en_US |
dc.contributor.author | Lok, Anna Suk-Fong | en_US |
dc.date.accessioned | 2006-04-19T13:51:03Z | |
dc.date.available | 2006-04-19T13:51:03Z | |
dc.date.issued | 2003-08 | en_US |
dc.identifier.citation | Wai, Chun-Tao; Greenson, Joel K.; Fontana, Robert J.; Kalbfleisch, John D.; Marrero, Jorge A.; Conjeevaram, Hari S.; Lok, Anna S.-F. (2003)."A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C." Hepatology 38(2): 518-526. <http://hdl.handle.net/2027.42/34794> | en_US |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.issn | 1527-3350 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/34794 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12883497&dopt=citation | en_US |
dc.description.abstract | Information on the stage of liver fibrosis is essential in managing chronic hepatitis C (CHC) patients. However, most models for predicting liver fibrosis are complicated and separate formulas are needed to predict significant fibrosis and cirrhosis. The aim of our study was to construct one simple model consisting of routine laboratory data to predict both significant fibrosis and cirrhosis among patients with CHC. Consecutive treatment-naive CHC patients who underwent liver biopsy over a 25-month period were divided into 2 sequential cohorts: training set (n = 192) and validation set (n = 78). The best model for predicting both significant fibrosis (Ishak score ≥ 3) and cirrhosis in the training set included platelets, aspartate aminotransferase (AST), and alkaline phosphatase with an area under ROC curves (AUC) of 0.82 and 0.92, respectively. A novel index, AST to platelet ratio index (APRI), was developed to amplify the opposing effects of liver fibrosis on AST and platelet count. The AUC of APRI for predicting significant fibrosis and cirrhosis were 0.80 and 0.89, respectively, in the training set. Using optimized cut-off values, significant fibrosis could be predicted accurately in 51% and cirrhosis in 81% of patients. The AUC of APRI for predicting significant fibrosis and cirrhosis in the validation set were 0.88 and 0.94, respectively. In conclusion, our study showed that a simple index using readily available laboratory results can identify CHC patients with significant fibrosis and cirrhosis with a high degree of accuracy. Application of this index may decrease the need for staging liver biopsy specimens among CHC patients. | en_US |
dc.format.extent | 149836 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | W.B. Saunders | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Hepatology | en_US |
dc.title | A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Pathology, University of Michigan Medical School, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Biostatistics, University of Michigan Medical School, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI ; Division of Gastroenterology, University of Michigan Medical Center, 3912 Taubman Center, Box 0362, Ann Arbor, MI 48109-0362. fax: 734-936-7392 | en_US |
dc.identifier.pmid | 12883497 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/34794/1/510380230_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1053/jhep.2003.50346 | en_US |
dc.identifier.source | Hepatology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.